{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:51:40Z","timestamp":1790815900293,"version":"4.1.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00469","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:28:50Z","timestamp":1600129730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges"],"prefix":"10.3389","volume":"10","author":[{"given":"Muluneh","family":"Ademe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-g: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1111\/j.1600-6143.2010.03094.x","article-title":"Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients","volume":"10","author":"Armstrong-James","year":"2010","journal-title":"Am. J. Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jcyt.2015.05.011","article-title":"Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer","volume":"17","author":"Bacher","year":"2015","journal-title":"Cytotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6010031","article-title":"Immunotherapy against systemic fungal infections based on monoclonal antibodies","volume":"6","author":"Boniche","year":"2020","journal-title":"J Fungi"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Bozza","year":"2003","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3181\/00379727-84-20539","article-title":"Transfusion of separated leukocytes into irradiated dogs with aplastic marrows","volume":"84","author":"Brecher","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"403121","DOI":"10.1155\/2013\/403121","article-title":"Human monoclonal antibody-based therapy in the treatment of invasive candidiasis","volume":"2013","author":"Bugli","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat. Rev. Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1086\/322710","article-title":"Adjunctive immune therapy for fungal infections","volume":"33","author":"Casadevall","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1473-3099(08)70016-1","article-title":"Fungal vaccines: real progress from real challenges","volume":"8","author":"Cassone","year":"2008","journal-title":"Lancet Infect. Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Brt. J. Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/mmy\/myw118","article-title":"Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1rightarrow3)-b-D-glucan","volume":"55","author":"Chen","year":"2017","journal-title":"Med Mycol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1634\/theoncologist.5-2-120","article-title":"New drugs and novel targets for treatment of invasive fungal infections in patients with cancer","volume":"5","author":"Chiou","year":"2000","journal-title":"Oncologist"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0091-6749(98)70185-X","article-title":"The therapeutic use of hematopoietic growth factors","volume":"101","author":"Costa","year":"1998","journal-title":"J Allergy Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/imr.12476","article-title":"Pentraxins in the activation and regulation of innate immunity","volume":"274","author":"Daigo","year":"2016","journal-title":"Immunol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jcyt.2014.03.009","article-title":"Opportunities and limitations of NK cells as adoptive therapy for malignant disease","volume":"16","author":"Davies","year":"2014","journal-title":"Cytotherapy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cti.2015.16","article-title":"Adoptive T-cell therapy for fungal infections in haematology patients","volume":"4","author":"Deo","year":"2015","journal-title":"Clin. Transl. Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"\u2018Off-the-shelf\u2019 allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat. Rev. Drug Discov"},{"key":"B25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3109\/08880018.2013.868562","article-title":"Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction","volume":"31","author":"D\u00edaz","year":"2014","journal-title":"Pediatr. Hematol. Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11046-005-5260-z","article-title":"Successful treatment of antifungal- and cryotherapy-resistant subcutaneous hyalohyphomycosis in an immunocompetent case with topical 5% imiquimod cream","volume":"159","author":"Erbagci","year":"2005","journal-title":"Mycopathologia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD005339.pub2","article-title":"Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction","volume":"4","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B28","unstructured":"FDA Approves CAR-T Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma2017"},{"key":"B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1086\/516361","article-title":"Monocyte-macrophages, granulocyte-macrophage colonystimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants","volume":"26","author":"Giles","year":"1998","journal-title":"Clin. Infect. Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/AAC.42.10.2467","article-title":"Granulocyte colony stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression","volume":"42","author":"Graybill","year":"1998","journal-title":"Antimicrob. Agents Chemother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00520-005-0910-8","article-title":"Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.bmt.1703332","article-title":"Late onset invasive Aspergillus infection in bone marrow transplant patients at a University hospital","volume":"29","author":"Grow","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15406\/moji.2016.04.00121","article-title":"Cytokines and their role in health and disease: a brief overview","volume":"4","author":"Gulati","year":"2016","journal-title":"MOJ Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nri2532","article-title":"Intravascular immunity: the host-pathogen encounter in blood vessels","volume":"9","author":"Hickey","year":"2009","journal-title":"Nat. Rev. Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2011-09-379214","article-title":"Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling","volume":"119","author":"Hume","year":"2012","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive Interferon-g immunotherapy for the treatment of HIV associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1084\/jem.20151975","article-title":"M-CSF improves protection against bacterial and fungal infections after hematopoietic stem\/progenitor cell transplantation","volume":"213","author":"Kandalla","year":"2016","journal-title":"J. Exp. Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/AAC.44.1.19-23.2000","article-title":"Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida Albicans Infection","volume":"44","author":"Kuhara","year":"2000","journal-title":"Antimicrob. Agents Chemother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2012\/920517","article-title":"Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response","volume":"2012","author":"Kunes","year":"2012","journal-title":"Mediat Inflamm"},{"key":"B43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/jof4040137","article-title":"Immunomodulation as a therapy for aspergillus infection: current status and future perspectives","volume":"4","author":"Lauruschkat","year":"2018","journal-title":"J. Fungi"},{"key":"B44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3109\/08820139.2011.581732","article-title":"Immunotherapy against invasive fungal diseases in stem cell transplant recipients","volume":"40","author":"Lehrnbecher","year":"2011","journal-title":"Immunol. Invest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob. Agents Chemother"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e28398","DOI":"10.4161\/onci.28398","article-title":"Myeloid-derived cells are key targets of tumor immunotherapy","volume":"3","author":"Medina-Echeverz","year":"2014","journal-title":"Oncoimmunology"},{"key":"B48","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis","volume":"162","author":"Mehrad","year":"1999","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18585\/inabj.v8i1.189","article-title":"Cancer immunotherapy: a review","volume":"8","author":"Meiliana","year":"2016","journal-title":"Indones Biomed J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1086\/315277","article-title":"Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis","volume":"181","author":"Mencacci","year":"2000","journal-title":"J. Infect. Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J. Infect. Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin. Infect. Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.2174\/138161206778743538","article-title":"Recognition of fungal pathogens by toll-like receptors","volume":"12","author":"Netea","year":"2006","journal-title":"Curr. Pharm. Des"},{"key":"B55","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bmt.2015.53","article-title":"Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-centre experience","volume":"50","author":"Nikolajeva","year":"2015","journal-title":"Bone Marrow Transplantation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2015.10.005","article-title":"Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: progress and challenges","volume":"98","author":"Papadopoulou","year":"2016","journal-title":"Crit. Rev. Oncol Hematol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00281-014-0462-4","article-title":"Pattern recognition receptors in antifungal immunity","volume":"37","author":"Plato","year":"2015","journal-title":"Semin. Immunopathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08977190500055836","article-title":"G-CSF: a key regulator of neutrophil production, but that's not all!","volume":"23","author":"Roberts","year":"2005","journal-title":"Growth Factors"},{"key":"B60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/2047-783X-16-4-187","article-title":"Epidemiology and antifungal resistance in invasive candidiasis","volume":"16","author":"Rodloff","year":"2011","journal-title":"Eur. J. Med. Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00062752-200005000-00012","article-title":"Concurrent use of growth factors and chemotherapy in acute leukemia","volume":"7","author":"Rowe","year":"2000","journal-title":"Curr. Opin. Hematol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chom.2012.04.005","article-title":"Dendritic cells in antifungal immunity and vaccine design","volume":"11","author":"Roy","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1038\/s41467-018-07738-1","article-title":"Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis","volume":"9","author":"Rudkin","year":"2018","journal-title":"Nat. Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/cid\/cit187","article-title":"Immunotherapy for invasive mold disease in severely immunosuppressed patients","volume":"57","author":"Safdar","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/cncr.20883","article-title":"The safety of interferongamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation","volume":"103","author":"Safdar","year":"2005","journal-title":"Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000342121","article-title":"Granulocyte macrophage colony stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease","volume":"129","author":"Safdar","year":"2013","journal-title":"Acta Haematol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3389\/fmicb.2018.01612","article-title":"Immunomodulation as therapy for fungal infection: are we closer?","volume":"9","author":"Sam","year":"2018","journal-title":"Front. Microbiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"71062","DOI":"10.18632\/oncotarget.12616","article-title":"Aspergillus fumigatus responds to natural killer (NK) cells with upregulation of stress related genes and inhibits the immunoregulatory function of NK cells","volume":"7","author":"Schneider","year":"2016","journal-title":"Oncotarget"},{"key":"B69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mib.2017.10.018","article-title":"Modulating host immune responses to fight invasive fungal infections","volume":"40","author":"Scriven","year":"2017","journal-title":"Curr. Opin. Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/499811","article-title":"Immunotherapy for fungal infections","volume":"42","author":"Segal","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/B:VERC.0000046743.27552.19","article-title":"DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease","volume":"29","author":"Shao","year":"2005","journal-title":"Vet. Res. Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"568543","DOI":"10.1155\/2015\/568543","article-title":"Pivotal roles of GM-CSF in autoimmunity and inflammation","volume":"2015","author":"Shiomi","year":"2015","journal-title":"Mediat Inflamm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jac\/dki252","article-title":"Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and GCSF","volume":"56","author":"Sionov","year":"2005","journal-title":"J. Antimicrob. Chemother"},{"key":"B74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0928-8244(03)00230-X","article-title":"Polyene and cytokine treatment of experimental aspergillosis","volume":"39","author":"Sionov","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1086\/505357","article-title":"Interferon- gamma as an antifungal","volume":"194","author":"Stevens","year":"2006","journal-title":"J. Infect. Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1570163810666131120150043","article-title":"Antibody discovery: sourcing of monoclonal antibody variable domains","volume":"11","author":"Strohl","year":"2014","journal-title":"Curr. Drug. Discov. Technol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/infdis\/jiv143","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis","volume":"212","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1293\/tox.2015-0031","article-title":"Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies","volume":"28","author":"Suzuki","year":"2015","journal-title":"J. Toxicol. Pathol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1128\/IAI.01700-14","article-title":"Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells","volume":"82","author":"Tramsen","year":"2014","journal-title":"Infect Immun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated coccidioidomycosis treated with interferon-\u03b3 and Dupilumab","volume":"382","author":"Tsai","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/21655979.2016.1212136","article-title":"Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): possibility of nanoparticle-mediated delivery in cancer immunotherapy","volume":"8","author":"Vanitha","year":"2017","journal-title":"Bioengineered"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial","volume":"33","author":"Wan","year":"2015","journal-title":"J. Clin. Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1182\/blood-2008-07-168419","article-title":"Paradoxical effects of IFN-\u03b3 in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury","volume":"113","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1189\/jlb.0611308","article-title":"Natural killer cell-produced IFN-\u03b3 and TNF-\u03b1 induce target cell cytolysis through up-regulation of ICAM-1","volume":"91","author":"Wang","year":"2012","journal-title":"J. Leukoc. Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bjh.14597","article-title":"Granulocyte transfusions in the management of invasive fungal infections","volume":"177","author":"West","year":"2017","journal-title":"Br. J. Haematol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1086\/377099","article-title":"Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species","volume":"188","author":"Winn","year":"2003","journal-title":"J. Infect. Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"7517350","DOI":"10.1155\/2017\/7517350","article-title":"Granulocyte colonystimulating factor and its potential application for skeletal muscle repair and regeneration","volume":"2017","author":"Wright","year":"2017","journal-title":"Mediat. Inflamm"},{"key":"B88","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00005-019-00540-x","article-title":"Significance and role of pattern recognition receptors in malignancy","volume":"67","author":"Zeromski","year":"2019","journal-title":"Archivum Immunol et Ther Exp"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T05:22:48Z","timestamp":1696656168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":88,"alternative-id":["10.3389\/fcimb.2020.00469"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00469","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"article-number":"469"}}